Canaccord Genuity Reiterates Buy on Clene, Maintains $94 Price Target
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Sumant Kulkarni has reiterated a Buy rating on Clene (NASDAQ:CLNN) and maintained a price target of $94.
August 06, 2024 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity analyst Sumant Kulkarni has reiterated a Buy rating on Clene and maintained a price target of $94.
The reiteration of a Buy rating and a high price target of $94 by a reputable analyst is likely to positively impact Clene's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100